The story of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge of knock-off medications, significantly impacting its dominance. While specific businesses may seek to capitalize on male sexual dysfunction